Labcorp and its Specialty Testing Group, a fully integrated portfolio of specialty and esoteric testing laboratories.
100-g glucose load; plasma glucose measured fasting, and at one, two, and three hours
The ADA 2011 standards1 vary from the ACOG recommendations.2 See Additional Information below.
Within 1 day
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Serum or plasma
1 mL serum or plasma each tube
0.5 mL serum or plasma each tube
Gel-barrier tubes (4) or gray-top (sodium fluoride/potassium oxalate plasma) tubes (4)
Draw a fasting blood sugar before administering 100-gram glucose, and draw blood at one, two, and three hours. The subject should remain seated and not smoke throughout the test. Submit 1 mL serum or plasma for fasting, one-hour, two-hour, and three-hour specimens. Separate serum or plasma from cells within 45 minutes of venipuncture. Gray-top tubes only, may be submitted without centrifugation. Label each tube with patient's name and collection time interval (ie, fasting, one-hour, two-hour, and three-hour).
Maintain specimen at room temperature.3
For three days prior to the test, patients should eat an unrestricted diet of 150 or more grams of carbohydrate and be permitted unrestricted physical activity. Patients should be instructed to eat and drink nothing except water for at least eight hours and not more than 14 hours before the test. Patients should also be advised to discontinue, whenever possible, all nonessential medication that can affect glucose metabolism at least three days before testing.
Frozen gray-top tube (frozen plasma from gray-top is acceptable); stressed patient (surgery, infection, corticosteroids) should not have GTT; specimens not labeled with collection time intervals (i.e., fasting, one-hour, two-hour, and three-hour)
Diagnose gestational diabetes
Plasma or Serum Glucose Level
(Carpenter and Coustan Conversion)
Plasma Glucose Level
(National Diabetes Data Group Conversion)
*The diagnosis of GDM can be made based on the result of the 100-gram, three-hour oral glucose tolerance test, for which there is evidence that treatment improves outcome. Either the plasma or serum glucose level established by Carpenter and Coustan or the plasma level designated by the National Diabetes Data Group is appropriate to use. A positive diagnosis requires that two or more high thresholds be exceeded. The Carpenter and Coustan conversion is used to establish LabCorp reference intervals.
In 2013,2 the American College of Obstetricians and Gynecologists (ACOG) recommended that all pregnant women be screened for gestational diabetes mellitus (GDM)—whether by patient history, clinical risk factors, or with a 50-gram, one-hour loading test at 24 to 28 weeks of gestation to determine blood glucose levels—and suggested relying on the result of the 100-gram, three-hour oral glucose tolerance test for diagnosis (often referred to as a "two-step" method).
The American Diabetes Association (ADA)1 released standards that vary from the ACOG recommendations. The ADA standards recommend a simplified "one-step" approach to the screen and diagnosis of gestational diabetes mellitus with a 75-gram, two-hour glucose tolerance test. The LabCorp test according to the ADA recommendations is Gestational Glucose Tolerance Screening and Diagnostics Test (Two-hour, ADA Recommendations) .
|Order Code||Order Code Name||Order Loinc||Result Code||Result Code Name||UofM||Result LOINC|
|102004||Gestational Glucose Tolerance||102012||Glucose - Fasting||mg/dL||1558-6|
|102004||Gestational Glucose Tolerance||102020||Glucose - 1 hour||mg/dL||1501-6|
|102004||Gestational Glucose Tolerance||102038||Glucose - 2 hour||mg/dL||1514-9|
|102004||Gestational Glucose Tolerance||102046||Glucose - 3 hour||mg/dL||1530-5|
|102004||Gestational Glucose Tolerance||102047||Note:||N/A|
|102004||Gestational Glucose Tolerance||102049||Gest Glucose Tolerance (4)||N/A|
© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.
The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf